Hisamitsu Pharmaceutical Co Inc
TSE:4530
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
JP |
|
I
|
Indofood CBP Sukses Makmur Tbk PT
XBER:48I
|
ID |
|
Portillos Inc
NASDAQ:PTLO
|
US |
|
Beacon Lighting Group Ltd
ASX:BLX
|
AU |
|
N
|
Northrop Grumman Corp
XMUN:NTH
|
US |
|
A
|
Andean Precious Metals Corp
XTSX:APM
|
CA |
|
Ardelyx Inc
NASDAQ:ARDX
|
US |
|
G
|
Gatos Silver Inc
TSX:GATO
|
US |
|
V
|
VSTECS Holdings Ltd
HKEX:856
|
HK |
|
Cherry SE
F:C3RY
|
DE |
|
D
|
Dongfang Electric Corp Ltd
OTC:DNGFF
|
CN |
|
Sovereign Metals Ltd
ASX:SVM
|
AU |
|
A
|
Angi Inc
F:2UH
|
US |
|
Thule Group AB
STO:THULE
|
SE |
|
W
|
WPP PLC
NYSE:WPP
|
UK |
|
Orange SA
XETRA:FTE
|
FR |
|
Sherritt International Corp
TSX:S
|
CA |
|
Pets at Home Group PLC
LSE:PETS
|
UK |
|
Solocal Group SE
F:QS30
|
FR |
|
H
|
HSBC Holdings PLC
NYSE:HSBC
|
UK |
|
Bell Food Group AG
SIX:BELL
|
CH |
|
A
|
Assicurazioni Generali SpA
XBER:ASG
|
IT |
|
A
|
Ansell Ltd
OTC:ANSLF
|
AU |
|
Hiab Oyj
F:C1C1
|
FI |
Wall St Price Targets
Price Targets Summary
Hisamitsu Pharmaceutical Co Inc
According to Wall Street analysts, the average 1-year price target for Hisamitsu Pharmaceutical Co Inc is 4 335 JPY with a low forecast of 4 242 JPY and a high forecast of 4 515 JPY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Hisamitsu Pharmaceutical Co Inc's stock price target?
Price Target
4 335
JPY
According to Wall Street analysts, the average 1-year price target for Hisamitsu Pharmaceutical Co Inc is 4 335 JPY with a low forecast of 4 242 JPY and a high forecast of 4 515 JPY.
What is the Revenue forecast for Hisamitsu Pharmaceutical Co Inc?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Hisamitsu Pharmaceutical Co Inc?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Operating Income has been -3%. The projected CAGR for the next 14 years is 2%.
What is the Net Income forecast for Hisamitsu Pharmaceutical Co Inc?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 3%.
